These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8903073)
1. Magnetic resonance imaging of corticobasal degeneration. Hauser RA; Murtaugh FR; Akhter K; Gold M; Olanow CW J Neuroimaging; 1996 Oct; 6(4):222-6. PubMed ID: 8903073 [TBL] [Abstract][Full Text] [Related]
2. [Putaminal signal hypointensity on T2 weighted MR image in a patient with corticobasal degeneration]. Tsunoda M; Yukino T; Koike H; Yoshino Y; Kamiyama M Rinsho Shinkeigaku; 2000 Jan; 40(1):59-61. PubMed ID: 10825804 [TBL] [Abstract][Full Text] [Related]
3. [Corticobasal degeneration. The significance of clinical criteria for establishing the diagnosis]. Feifel E; Brenner M; Teiwes R; Lücking CH; Deuschl G Nervenarzt; 1994 Oct; 65(10):653-9. PubMed ID: 7808563 [TBL] [Abstract][Full Text] [Related]
4. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy]. Lass P; Sławek J; Derejko M; Dubaniewicz M Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354 [TBL] [Abstract][Full Text] [Related]
5. [Corticobasal degeneration: a combined clinical, PET and pathological study]. Sato M; Nagata K; Yokoyama E; Hirata Y Rinsho Shinkeigaku; 1996 Feb; 36(2):293-9. PubMed ID: 8752683 [TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213 [TBL] [Abstract][Full Text] [Related]
7. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy]. Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604 [TBL] [Abstract][Full Text] [Related]
8. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Hayashi T; Konishi J; Kimura J Arch Neurol; 1998 May; 55(5):609-14. PubMed ID: 9605717 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. Savoiardo M; Girotti F; Strada L; Ciceri E J Neural Transm Suppl; 1994; 42():93-110. PubMed ID: 7964700 [TBL] [Abstract][Full Text] [Related]
13. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration. Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692 [TBL] [Abstract][Full Text] [Related]
14. Diffuse cerebral white matter T2-weighted hyperintensity: a new finding of general paresis. Alam F; Yasutomi H; Fukuda H; Horiguchi J; Murakami Y; Ohshita T; Inoue K; Ito K Acta Radiol; 2006 Jul; 47(6):609-11. PubMed ID: 16875341 [TBL] [Abstract][Full Text] [Related]
15. [A lateralized reduction of NAA in a case of corticobasal degeneration (CBD): application of proton magnetic resonance spectroscopy (1H-MRS)]. Nakase T; Mizuno T; Takanashi Y; Nakajima K; Imahori Y; Furuya S; Naruse S No To Shinkei; 1998 May; 50(5):421-5. PubMed ID: 9621363 [TBL] [Abstract][Full Text] [Related]
16. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375 [TBL] [Abstract][Full Text] [Related]
17. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome. Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887 [TBL] [Abstract][Full Text] [Related]
18. [Corticobasal degeneration: symptomatological, brain-imaging and electrophysiological studies]. Morimatsu M; Negoro K Rinsho Shinkeigaku; 1995 Dec; 35(12):1459-62. PubMed ID: 8752430 [TBL] [Abstract][Full Text] [Related]
19. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome. Desaloms JM; Krauss JK; Lai EC; Jankovic J; Grossman RG J Neurosurg; 1998 Aug; 89(2):194-9. PubMed ID: 9688112 [TBL] [Abstract][Full Text] [Related]
20. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Soliveri P; Monza D; Paridi D; Radice D; Grisoli M; Testa D; Savoiardo M; Girotti F Neurology; 1999 Aug; 53(3):502-7. PubMed ID: 10449111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]